ARTICLE | Distillery Therapeutics
Therapeutics: C. albicans cytochrome bc1
August 25, 2016 7:00 AM UTC
Mouse, in vitro and cell culture studies identified an indazole-based inhibitor of Candida albicans cytochrome bc1 that could help treat candidiasis resistant to fluconazole and other triazole-based d...